Roche/Sanofi on joint multinational clinical studies for cancer drugs.

Published: 2006-04-07 06:57:00

Updated: 2006-04-07 06:57:00

The phase III clinical study called CLASSIC (Capecitabine and OxaLiplatin Adjuvant Study in Stomach Cancer) for an adjuvant cancer therapy after the stomach surgical operation may be jointly conducted by Roche Korea and Sanofi-Aventis Korea to assess the effects of Xeloda (Capecitabine) and Eloxatin (Oxaliplatin).

Two companies said that the study was designed as an adjuvant therapy for stom...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.